1. Home
  2. VIR vs AMTB Comparison

VIR vs AMTB Comparison

Compare VIR & AMTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • AMTB
  • Stock Information
  • Founded
  • VIR 2016
  • AMTB 1979
  • Country
  • VIR United States
  • AMTB United States
  • Employees
  • VIR N/A
  • AMTB N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • AMTB Major Banks
  • Sector
  • VIR Health Care
  • AMTB Finance
  • Exchange
  • VIR Nasdaq
  • AMTB Nasdaq
  • Market Cap
  • VIR 706.4M
  • AMTB 837.4M
  • IPO Year
  • VIR 2019
  • AMTB N/A
  • Fundamental
  • Price
  • VIR $5.65
  • AMTB $20.29
  • Analyst Decision
  • VIR Strong Buy
  • AMTB Hold
  • Analyst Count
  • VIR 8
  • AMTB 5
  • Target Price
  • VIR $30.25
  • AMTB $24.33
  • AVG Volume (30 Days)
  • VIR 1.2M
  • AMTB 243.5K
  • Earning Date
  • VIR 08-04-2025
  • AMTB 07-23-2025
  • Dividend Yield
  • VIR N/A
  • AMTB 1.78%
  • EPS Growth
  • VIR N/A
  • AMTB N/A
  • EPS
  • VIR N/A
  • AMTB N/A
  • Revenue
  • VIR $20,861,000.00
  • AMTB $280,716,000.00
  • Revenue This Year
  • VIR N/A
  • AMTB $57.57
  • Revenue Next Year
  • VIR $0.62
  • AMTB $8.91
  • P/E Ratio
  • VIR N/A
  • AMTB N/A
  • Revenue Growth
  • VIR N/A
  • AMTB N/A
  • 52 Week Low
  • VIR $4.32
  • AMTB $16.21
  • 52 Week High
  • VIR $14.45
  • AMTB $26.24
  • Technical
  • Relative Strength Index (RSI)
  • VIR 54.74
  • AMTB 66.59
  • Support Level
  • VIR $5.31
  • AMTB $19.65
  • Resistance Level
  • VIR $5.92
  • AMTB $21.35
  • Average True Range (ATR)
  • VIR 0.30
  • AMTB 0.60
  • MACD
  • VIR 0.02
  • AMTB 0.02
  • Stochastic Oscillator
  • VIR 43.69
  • AMTB 54.68

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About AMTB Amerant Bancorp Inc.

Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.

Share on Social Networks: